Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|August 21, 2019
Mass Cytometry Discovers Two Discrete Subsets of CD39-Treg Which Discriminate MGUS From Multiple MyelomaFelix Marsh-Wakefield, Annabel Kruzins, Helen M McGuire, et al.
Open Forum Infectious Diseases|May 13, 2022
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell TransplantationJulian Lindsay, Jad Othman, Yvonne Kong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2020
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient RegistryYadanar Lwin, Glenn Kennedy, David Gottlieb, et al.
Oncoimmunology|April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remissionJennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.
Pathology|September 17, 2011
Mobilisation strategies for normal and malignant cellsL Bik To, Jean-Pierre Levesque, Kirsten E Herbert, et al.
Internal Medicine Journal|May 3, 2025
Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern eraLuani Barge, Steven Tran, Glen Kennedy, et al.
Blood Advances|September 28, 2020
Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patientsSlavica Vuckovic, Christian E Bryant, Ka Hei Aleks Lau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2020
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATGJad Othman, Matthew Greenwood, John Moore, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic SyndromesGuillermo Garcia-Manero, Valeria Santini, Antonio Almeida, et al.
Pageof 4